top of page

Search


MUVON enters TOP 100 SWISS STARTUPS list as a top 3 Biotech
We are extremely proud to announce that MUVON has entered the prestigious Top 100 Swiss Startups list as the highest ranked newcomer in 2023. Ranked at Number 19 overall, we also have the honor to have been selected as one of the top 3 Biotech Startups of Switzerland. Since 2011, Switzerland celebrates the most promising Swiss startups at the TOP 100 Award Night . The Swiss Startup Ranking, organized by Venturelab , features startups that are not older than five years and are
Sep 7, 20231 min read


MUVON Therapeutics AG among the TOP 3 Swiss biotech leaders according to public voting
It is the third consecutive year for MUVON Therapeutics AG to make it into the leading race for the most innovative Swiss biotech start up by public voting. Thanks to all who believe in us and are constantly supporting our mission on the way towards bringing a bright future to our patients. If you have not voted yet, you can still do it! https://lnkd.in/eD4fvDZg
Jun 12, 20231 min read


MUVON finishes as Top 3 finalist for the ZKB Pionierpreis 2023 with our tissue engineering therapy
With our novel therapy platform for skeletal muscle regeneration, the MUVON team has won the prize of 10k as a runner up for the ZKB Pionierpreis 2023. The Pionierpreis or "pioneer award" is considered the leading innovation award for deep-tech start-ups in Switzerland and a significant achievement for young companies. The Pioneer Award honors projects at the transition from an innovative idea to marketability. At this point, start-ups are still usually a long way from maki
Jun 2, 20231 min read
INVEST IN OUR
INNOVATION
Invest in us to be part of a groundbreaking journey toward innovative, life-changing muscle regeneration therapies, addressing a massive global market with scalable solutions.
bottom of page
